Dexcom (DXCM) Total Non-Current Liabilities (2016 - 2026)
Dexcom has reported Total Non-Current Liabilities over the past 17 years, most recently at $3.5 billion for Q1 2026.
- Quarterly Total Non-Current Liabilities fell 18.46% to $3.5 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $3.5 billion through Mar 2026, down 18.46% year-over-year, with the annual reading at $3.5 billion for FY2025, 18.36% down from the prior year.
- Total Non-Current Liabilities was $3.5 billion for Q1 2026 at Dexcom, up from $3.5 billion in the prior quarter.
- Over five years, Total Non-Current Liabilities peaked at $4.6 billion in Q3 2025 and troughed at $2.8 billion in Q1 2022.
- The 5-year median for Total Non-Current Liabilities is $4.1 billion (2024), against an average of $3.8 billion.
- Year-over-year, Total Non-Current Liabilities surged 60.28% in 2023 and then fell 18.46% in 2026.
- A 5-year view of Total Non-Current Liabilities shows it stood at $3.1 billion in 2022, then rose by 29.98% to $4.1 billion in 2023, then grew by 4.02% to $4.2 billion in 2024, then dropped by 18.36% to $3.5 billion in 2025, then rose by 2.25% to $3.5 billion in 2026.
- Per Business Quant, the three most recent readings for DXCM's Total Non-Current Liabilities are $3.5 billion (Q1 2026), $3.5 billion (Q4 2025), and $4.6 billion (Q3 2025).